Ameritas Investment Partners’s iRadimed IRMD Stock Holding History

Ameritas Investment Partners’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.9K	Hold	721	–	–	﹤0.01%	2052
2026 Q1	$69.4K	Hold	721	–	–	﹤0.01%	1892
2025 Q4	$70.1K	Hold	721	–	–	﹤0.01%	1903
2025 Q3	$51.3K	Hold	721	–	–	﹤0.01%	2100
2025 Q2	$43.1K	Hold	721	–	–	﹤0.01%	2277
2025 Q1	$37.8K	Hold	721	–	–	﹤0.01%	2266
2024 Q4	$39.7K	Hold	721	–	–	﹤0.01%	2325
2024 Q3	$36.3K	Hold	721	–	–	﹤0.01%	2371
2024 Q2	$31.7K	Hold	721	–	–	﹤0.01%	2391
2024 Q1	$31.7K	Hold	721	–	–	﹤0.01%	2378
2023 Q4	$34.2K	Hold	721	–	–	﹤0.01%	2349
2023 Q3	$32K	Buy	721 +231	+47%	+$10.7K	﹤0.01%	2324
2023 Q2	$23.4K	Hold	490	–	–	﹤0.01%	2483
2023 Q1	$19.3K	Hold	490	–	–	﹤0.01%	2483
2022 Q4	$17.3K	Hold	490	–	–	﹤0.01%	2624
2022 Q3	$14K	Hold	490	–	–	﹤0.01%	2681
2022 Q2	$16K	Hold	490	–	–	﹤0.01%	2653
2022 Q1	$22K	Hold	490	–	–	﹤0.01%	2516
2021 Q4	$23K	Buy	490 +208	+74%	+$8.39K	﹤0.01%	2574
2021 Q3	$9K	Hold	282	–	–	﹤0.01%	2964
2021 Q2	$8K	Hold	282	–	–	﹤0.01%	2960
2021 Q1	$7K	Hold	282	–	–	﹤0.01%	2946
2020 Q4	$6K	Hold	282	–	–	﹤0.01%	2940
2020 Q3	$6K	Hold	282	–	–	﹤0.01%	2922
2020 Q2	$7K	Hold	282	–	–	﹤0.01%	2874
2020 Q1	$6K	Hold	282	–	–	﹤0.01%	2755
2019 Q4	$7K	Hold	282	–	–	﹤0.01%	2834
2019 Q3	$6K	Hold	282	–	–	﹤0.01%	2893
2019 Q2	$6K	Hold	282	–	–	﹤0.01%	2920
2019 Q1	$8K	Hold	282	–	–	﹤0.01%	2761
2018 Q4	$7K	Hold	282	–	–	﹤0.01%	2779
2018 Q3	$10K	Hold	282	–	–	﹤0.01%	2831
2018 Q2	$6K	Buy	+282	New	+$4.99K	﹤0.01%	2915
2017 Q2	–	Sell	-219	Closed	-$2K	–	3020
2017 Q1	$2K	Buy	+219	New	+$2.03K	﹤0.01%	2921

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameritas Investment Partners's IRMD Position: Q2 2026 in Review

Ameritas Investment Partners held its iRadimed (IRMD) position steady in Q2 2026 at 721 shares worth $68.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

Ameritas Investment Partners first reported a position in IRMD in Q1 2017 and has held it in 34 quarters since. The position peaked at $70.1K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Ameritas Investment Partners held 721 shares of iRadimed worth $68.9K as of Q2 2026.
Ameritas Investment Partners left its iRadimed share count unchanged in Q2 2026.
iRadimed made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2052 holding.
Ameritas Investment Partners first reported a position in iRadimed in Q1 2017 and has held it in 34 quarters since.
Ameritas Investment Partners's iRadimed position peaked at $70.1K in Q4 2025.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.